Biotechnology News

June 11, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (“KYTHERA”) today announced the presentation of initial trial results from Study ATX-101-10-17, the second of two pivotal European Phase III clinical trials with ATX-101, a facial...

June 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome announced the start of its early technology access program for knomeCLINIC, a software suite designed to help medical researchers and clinicians interpret human genomes for biological relevance.

June 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome, Inc., the human genome interpretation company, today announced that it has appointed Gary A. Cohen, JD, MPH, as Senior Vice President, General Counsel and Secretary of the company.

June 11, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the Company plans to initiate two new LibiGel Phase III efficacy trials. This decision is based on an extensive analysis of previous efficacy...

June 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, InVivo’s Chief Executive...

June 11, 2012

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--MindChild Medical, Inc., today announced results of a recently sponsored national survey of hospital administrators and obstetricians (NSFM3) focused on trends in fetal monitoring. Recent fetal monitoring...

June 11, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac and VTU Technology announced today their collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for...

June 10, 2012

ZURICH--(BUSINESS WIRE)--Meet the 25 companies and organizations in the SWISS Pavilion at BIO 2012 and get to know more about the highly successful Swiss Biotech industry.

June 9, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that detailed findings from the Harmony 6 Phase 3 study comparing albiglutide to prandial insulin (Lispro), were presented...

June 9, 2012

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US & UK.Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced results from a post-hoc analysis that showed linagliptin is associated with...

June 9, 2012

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) presented results from a randomised Phase III clinical trial and a post-hoc analysis for linagliptin at ADA. The results showed...

June 9, 2012

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US & UK.Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) presented study results that showed the investigational SGLT-2 inhibitor empagliflozin*, alone...

June 9, 2012

PHILADELPHIA--(BUSINESS WIRE)--Amylin will be presenting data at the American Diabetes Association's Scientific Sessions.

June 9, 2012

PHILADELPHIA--(BUSINESS WIRE)--Amylin will be presenting data at the American Diabetes Association's Scientific Sessions.

June 9, 2012

PHILADELPHIA--(BUSINESS WIRE)--Amylin will be presenting data at the American Diabetes Association's Scientific Sessions.

June 9, 2012

PHILADELPHIA--(BUSINESS WIRE)--Amylin will be presenting data at the American Diabetes Association's Scientific Sessions.

June 8, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Perjeta™ (pertuzumab). Perjeta is approved in...

June 8, 2012

MIAMI BEACH, Fla.--(BUSINESS WIRE)--Best Cyclotron Systems unveils five new cyclotrons at the Society of Nuclear Medicine (SNM) Annual Meeting June 9–12, 2012 in Miami Beach, Florida, USA.

June 8, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it will present at the following conferences: William Blair Growth Stock ConferenceTuesday, June 12th, 2012, at 2:10 p.m. Central Daylight TimeFour Seasons...

June 8, 2012

ZURICH & GRENOBLE, France--(BUSINESS WIRE)--Leaders from the medtech industry gathered last week for the fourth annual EuroMedtech™ partnering conference held in Grenoble, France, May 31–June 1, 2012 at the Convention Center of the WTC...

June 8, 2012

RIO DE JANEIRO--(BUSINESS WIRE)--Cryopraxis® shows highest safety level in cord blood collection and manipulation

June 8, 2012

--(BUSINESS WIRE)--The Biotechnology Association of Alabama is a statewide organization representing Alabama’s bio related industries, research scientists, clinicians and business professionals who are working together to foster, develop and...

June 8, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck is proud to support the first Partners Against Mortality in Epilepsy (PAME) conference taking place at the Hilton Orrington in Evanston, IL, a suburb of Chicago, June 21-24, 2012. The conference will...

June 8, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today issued the following statement regarding the extension by GlaxoSmithKline plc (GSK) of its unsolicited tender offer to acquire all the outstanding common shares of...

June 8, 2012

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience Raises $5.0 million in Series A Financing

June 8, 2012

LEIDEN, Netherlands & AARHUS, Denmark--(BUSINESS WIRE)--CLC bio announces the completion and implementation of a specialized antibody engineering and selection module for Crucell, one of the Janssen Pharmaceutical Companies of Johnson &...

June 8, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/...

June 8, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex: (STO:ALNX) The transplantation unit at Jackson Memorial Hospital and the University of Miami, FL, USA has entered into a research project with the Allenex group company AbSorber. The project...

June 7, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. (NasdaqGS: ALTH) (Allos) today announced that Spectrum has provided an additional extension of the...

June 7, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) will host an Investor Day for institutional investors and research analysts on Thursday, June 21, 2012 from 8:00 a.m. to 1:00 p.m. ET in New York, New York. The meeting will...

June 7, 2012

MOUNTLAKE TERRACE, Wash.--(BUSINESS WIRE)--Dataworks Development announces a new release of its Freezerworks sample management and freezer inventory software program.

June 7, 2012

BOSTON--(BUSINESS WIRE)--H&Q Healthcare Investors announced that it has scheduled its annual meeting of shareholders for Monday, June 11, 2012, at 9:00 a.m., with a record date of April 30, 2012. The meeting will be held at the offices of the...

June 7, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $500,000 through its Biotech Investment Award (BIA) program to Modulation Therapeutics. Since the inception of this MMRF program...

June 7, 2012

FLEMINGTON, N.J.--(BUSINESS WIRE)--Arno Therapeutics, Inc. (OTCBB: ARNI) announced today that its investigational compound known as AR-42 has been granted orphan-drug designation by the European Medicines Agency (EMA) for the treatment of...

June 7, 2012

DUBLIN, Ohio & ANDOVER, Mass.--(BUSINESS WIRE)--Navidea Biopharmaceuticals today opened its new business and commercialization facility in Andover, Mass. with a ribbon cutting ceremony attended by Mass. Governor Deval Patrick and other...

June 7, 2012

NEW YORK--(BUSINESS WIRE)--Kansas workers compensation plan adopts guideline for exclusive use of STAR ankle total ankle replacement.

June 7, 2012

WASHINGTON--(BUSINESS WIRE)--A coalition of farm, renewable energy, and bioproduct organizations wrote to Senate Agriculture Committee leaders to express strong support for the Farm Bill and its energy title.

June 7, 2012

HAWTHORNE, N.J.--(BUSINESS WIRE)--Proteonomix, Inc. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon human cells and their derivatives, announces the oral presentation by Chief Scientific Officer Ian McNiece,...

June 7, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA [OSL:DIAG] (OSE:DIAG) today announced that the first patient with MCI (Mild Cognitive Impairment) was examined with [18F] Flutemetamol PET imaging at University of Lund Sweden in the...

June 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences announced today the publication of a new study characterizing two protein antigens that may hold utility in the design of novel vaccines for Chlamydia trachomatis. The research, led by...

June 7, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced the recipients of its latest Thought Leader award: Dr. Jens Frisvad and the Center for Microbial Biotechnology in the Department of Systems Biology at the...

June 7, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic shareholders voted in favor of all proposals identified in the Proxy Statement at the Company's annual meeting of stockholders.

June 7, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of the novel Biopump™ technology for the sustained production and delivery of therapeutic proteins in patients using their...

June 7, 2012

EXTON, Pa.--(BUSINESS WIRE)--The majority of physicians surveyed by BioTrends report high satisfaction ratings for their patients' responses to their current UAL therapies